AMDL Inc has chosen AmScot Medical Laboratory, as one of the reference laboratories in the U.S. to make available oncology testing using the Company's DR-70 test kit.

Founded in 1987, AmScot Medical Laboratory, Cincinnati, Ohio, is a full-service laboratory. "AmScot Labs was chosen because of its outstanding record of quality and its philosophy of providing new biomarkers that offer detection and prevention of life-threatening diseases at the earliest possible stages," Dreher said.

"There are already several thousand people who have requested DR-70 and are anxious to be tested," Dreher said. DR-70 is a non-invasive blood test that has been shown in clinical trials to detect the presence of 13 or more cancers 84 percent of the time overall. Clinical trials have been conducted in China, Canada, Taiwan, and Turkey. DR-70 is made available to U.S. physicians and laboratories under a labeling exemption called "research use only."

AmScot Medical Laboratory is licensed by the U.S. Department of Health and Human Services to perform interstate testing. It says that its participation in independent quality assurance programs, such as the College of American Pathologists, demonstrates its dedication to accuracy and precision during laboratory testing.